Omthera Pharmaceuticals, Inc. 4
4 · Omthera Pharmaceuticals, Inc. · Filed Jul 10, 2013
Insider Transaction Report
Form 4
HORNER GEORGE F III
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2013-07-10−204,308→ 0 totalExercise: $0.33Exp: 2020-04-07→ Common Stock (204,308 underlying) - Exercise/Conversion
Common Stock
2013-07-10$0.33/sh+204,308$67,422→ 204,308 total
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger by and among Omthera Pharmaceuticals, Inc., Zeneca, Inc. and KAFA Acquisition Corp., dated May 27, 2013, this stock option has been accelerated and is fully vested.